Where does Obalon Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Obalon Therapeutics, Inc. ranks #12,147 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Obalon Therapeutics, Inc. hold?

Obalon Therapeutics, Inc. holds 25 US utility patents granted between 2015 and 2020, spanning 5 technology areas.

What is Obalon Therapeutics, Inc.'s Innovation Score?

Obalon Therapeutics, Inc. has an Innovation Score of 30.6 out of 100 (35th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Obalon Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Obalon Therapeutics, Inc.'s recent grant velocity is -44% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Obalon Therapeutics, Inc.'s patents?

Obalon Therapeutics, Inc.'s patents average 19.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Obalon Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Obalon Therapeutics, Inc.

Q: What technology areas does Obalon Therapeutics, Inc. focus on?

Obalon Therapeutics, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 25 patents, ranking #260 of 3,082 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 25 granted patents across 5 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Obalon ranks #12,147 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 5 technology areas.

#12,147
of 49,997 US assignees by volume: 35th percentile
by Innovation Score (30.6/100): 19.0
avg claims per patent: -44%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12147 · US Corporation #12,147 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 25 grants
UPPER-Q #12,147/49,997
PHOTO-FINISH OBP Medical
CPC-NARROW A61F · 5 areas
INNOV-THIN 30.6/100
CLAIMS-RICH 19.0 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -44% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: OBP Medical Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Obalon’s 30.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.3 pts (37%) Velocity 0.0 pts (0%) Breadth 7.9 pts (26%) Claim depth 11.4 pts (37%)

Qualcomm Incorporated · highest

85
Dongguan HaoHong… · near

31
Obalon Therapeutics · this assignee

31
SpotOn Transact · near

31
Kind Consumer · near

31
Liburdi Engineering · near

31
3D Lighting… · lowest

7

What this shows Obalon's Innovation Score is 30.6/100 (35th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Obalon?

Each dot is one of Obalon’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Obalon’s own 19.0 claims/patent is at or below the 19.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Obalon vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Obalon's grants concentrate

Obalon Therapeutics, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2020 (9 grants) versus a trough of 2 in 2016. By volume, Obalon sits between OBP Medical Corporation and Oscor Inc..

OBP Medical

25
Opko Ireland Glob…

25
Optimizely

25
OPW Fueling Compo…

25
Oetiker Schweiz

25
Onyx Therapeutics

25
Optodot

25
Oscor

25
Obalon Therapeuti… ◀

25

What this shows Obalon holds 25 patents at rank #12,149, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Obalon

By rank, the assignees closest to #12,149 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Obalon's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Obalon, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Obalon ranks #260 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (31 here).

Dongguan HaoHong Outdoor Products Technology Co., Ltd 31 SpotOn Transact, LLC 31 Kind Consumer Limited 31 Liburdi Engineering Limited 31

Obalon's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 35th percentile higher than 35% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Obalon Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	16.0%
2016	2	8.0%
2017	3	12.0%
2018	2	8.0%
2019	5	20.0%
2020	9	36.0%

Which technologies does Obalon Therapeutics, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 25

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 20

A61B - DIAGNOSIS; SURGERY; Identification 8

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 6

Y10T - Technical Subjects Covered BY Former US Classification 6

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Obalon Therapeutics, Inc.'s patent record in context - here's where to go next.

Obalon Therapeutics, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #12,147 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Obalon Therapeutics, Inc. against OBP Medical Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.